Campani, Daniela
University of Pisa
4 papers on CoChatORCID 0000-0001-5987-734X
Most cited papers
- Verified
PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer.
Loupakis, F., Pollina, L., Stasi, I., Ruzzo, A., Scartozzi, M., Santini, D., Masi, G., Graziano, F., Cremolini, C., Rulli, E., et al. (2009) · Journal of Clinical Oncology
Colorectal Cancer Treatments and StudiesLung Cancer Treatments and Mutations
Cited by 403
- Verified
Are we overestimating the loss of beta cells in type 2 diabetes?
Marselli, L., Suleiman, M., Masini, M., Campani, D., Bugliani, M., Syed, F., Martino, L., Focosi, D., Scatena, F., Olimpico, F., et al. (2014) · Diabetologia
Pancreatic function and diabetesDiabetes Treatment and Management
Cited by 136
- Verified
Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine
Bocci, G., Danesi, R., Marangoni, G., Fioravanti, A., Boggi, U., Esposito, I., Fasciani, A., Boschi, E., Campani, D., Bevilacqua, G., et al. (2004) · European Journal of Pharmacology
Angiogenesis and VEGF in CancerPancreatic and Hepatic Oncology Research
Cited by 49
- Verified
Nesidioblastosis and Insulinoma: A Rare Coexistence and a Therapeutic Challenge
Dardano, A., Daniele, G., Lupi, R., Napoli, N., Campani, D., Boggi, U., Del Prato, S., & Miccoli, R. (2020) · Frontiers in Endocrinology
Neuroendocrine Tumor Research AdvancesPancreatic function and diabetes
Cited by 14
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free